FortuneCommentary: ESG investors shouldn't ignore biotech's potential to deliver changeMay 2, 2022more_vert
MIT Sloan Management ReviewWhat's Lost When We Talk 'ESG' and Not 'Sustainability'May 5, 2022Andrew S. WinstonBy Andrew S. Winstonmore_vert